Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended March 31, 2025
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals Limited has submitted a regulatory compliance certificate to the Exchange covering the quarter ended March 31, 2025. This certificate, filed under SEBI's Depositories and Participants Regulations, is typically issued by the company's Registrar and Share Transfer Agent (RTA). It confirms that share certificates were despatched within the stipulated 30-day timeline and that the register of members has been properly updated. This is a periodic, procedural compliance filing mandated by SEBI rules.
This is a routine regulatory filing with no direct impact on the company's financials, business operations, or stock price. It simply reflects the company's adherence to SEBI's procedural norms around share transfers and depositary records.